IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. (2015)

First Author: Monticelli LA
Attributed to:  Use of EGF-R antagonists for the treatment of infections and tumour growth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1509070112

PubMed Identifier: 26243875

Publication URI: http://europepmc.org/abstract/MED/26243875

Type: Journal Article/Review

Volume: 112

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 34

ISSN: 0027-8424